
Physician-reviewed women’s hormone education
For many women, the first sign is not menopause itself but perimenopause—the years of hormonal transition leading up to the final menstrual period.
Medically reviewed by Dr. Timothy Mackey
Medical Director · Updated September 2026

The earliest sign of perimenopause is often a change in menstrual cycles. Periods may become shorter, longer, heavier, lighter or less predictable. Hot flashes, night sweats, sleep disruption, vaginal dryness, mood changes and changes in sexual function can appear before periods stop completely.
Menopause is diagnosed retrospectively after 12 consecutive months without a menstrual period when there is no other cause. Symptoms can begin years before that point.
Perimenopause is the transition during which ovarian hormone production becomes more variable. Menopause is the point reached after 12 months without menstruation. Postmenopause refers to the years afterward.
Most natural menopause occurs in midlife, but timing varies. Symptoms before age 45 deserve additional evaluation because early menopause and primary ovarian insufficiency can carry different health implications.
Cycle changes are often the earliest clue. Periods may come closer together, farther apart, change in flow or become less predictable. Irregular bleeding is common during perimenopause, but not every bleeding pattern should be automatically attributed to hormones.
Vasomotor symptoms can produce sudden heat, flushing, sweating or chills. When they occur during sleep, they can lead to repeated awakenings and daytime fatigue.
Some women develop difficulty falling asleep, staying asleep or returning to sleep after a night sweat. Sleep problems may also have causes unrelated to menopause, including sleep apnea, stress, medications and mood disorders.
Declining estrogen can cause genitourinary symptoms such as dryness, burning, discomfort with intercourse, urinary urgency or recurrent urinary symptoms. These can persist or worsen after menopause if untreated.
Sexual desire can change during perimenopause and menopause, but libido is influenced by many factors, including relationship health, sleep, mood, medications, vaginal discomfort and overall health. See our guide to low sex drive in women.
Irritability, mood swings, anxiety, low mood and “brain fog” are commonly reported during the menopausal transition. These symptoms are real but nonspecific, so persistent or severe symptoms should not be assumed to be hormonal without evaluation.
Midlife is often accompanied by changes in fat distribution, muscle mass and weight regulation. Menopause may contribute, but aging, activity, sleep, nutrition and metabolic health also matter. Hormone therapy should not be presented as a stand-alone weight-loss treatment.
Not always. In women over 45 with typical symptoms and changing menstrual patterns, menopause or perimenopause can often be assessed clinically without relying on a single hormone value.
FSH and estradiol can fluctuate substantially during perimenopause, which is why one isolated result may be misleading. Testing is more useful when symptoms occur unusually early, the diagnosis is unclear, periods are absent for another possible reason, or another endocrine condition is suspected.
Perimenopause commonly changes bleeding patterns, but heavy bleeding, bleeding after sex, bleeding between periods, prolonged bleeding or any bleeding after menopause deserves medical evaluation. Age, fibroids, medications, endometrial conditions and other gynecologic causes need to be considered.
Menopausal hormone therapy can be highly effective for vasomotor symptoms and can also help selected genitourinary symptoms. The right regimen depends on whether a woman has a uterus, symptom pattern, age, time since menopause, medical history and individual risk factors.
Systemic estrogen generally requires endometrial protection with a progestogen in women who still have a uterus. Vaginal estrogen is a different treatment strategy that can be used for local genitourinary symptoms with lower systemic exposure.
For a deeper treatment-focused discussion, see the dedicated estrogen therapy for women page. This article is intentionally focused on recognizing the menopausal transition rather than duplicating that treatment page.
Progesterone or another progestogen may be used with systemic estrogen in women with an intact uterus to reduce the risk of endometrial hyperplasia and cancer from unopposed estrogen. It may also have other regimen-specific roles depending on the clinical situation.
Read more in our progesterone and menopause guide.
Testosterone should not be treated as a routine component of every menopause regimen. The strongest evidence supports carefully selected use for hypoactive sexual desire disorder in postmenopausal women after a broader biopsychosocial evaluation. Dosing and monitoring differ substantially from male TRT.
See our women’s hormone therapy overview.
Women who cannot or do not want to use hormone therapy still have evidence-based options. Depending on symptoms and medical history, treatment may include certain SSRIs/SNRIs, gabapentin, fezolinetant or other therapies. Vaginal moisturizers and lubricants can help genitourinary symptoms, while CBT can improve coping with hot flashes and sleep disruption in some women.
Treatment should match the symptom rather than use a one-size-fits-all “menopause supplement” approach.
Fezolinetant (Veozah) carries an FDA boxed warning for rare but serious liver injury. It requires liver testing before use, monthly for three months, and at months six and nine. Symptoms suggesting liver injury require stopping the medicine and prompt medical advice.
Regular exercise, resistance training, adequate protein, smoking avoidance, moderation of alcohol, healthy sleep habits and management of cardiovascular and metabolic risk support long-term health during and after menopause.
These strategies are important for bone, muscle, cardiovascular and metabolic health, even when they do not eliminate every hot flash or vaginal symptom.
Consider evaluation when symptoms are disrupting sleep, work, relationships or sexual health; when periods change significantly; when symptoms begin unusually early; or when you are unsure whether symptoms are due to menopause or another condition.
Prompt evaluation is warranted for postmenopausal bleeding, very heavy bleeding, new breast symptoms, severe depression, chest pain, neurologic symptoms or other concerning changes.
For many women, the first sign is a change in menstrual-cycle timing or flow during perimenopause.
Yes. Hot flashes and night sweats often begin during perimenopause before menstruation has stopped completely.
Natural menopause is generally defined as 12 consecutive months without a menstrual period when another cause is not responsible.
Not necessarily. Hormone therapy is one effective option, but the choice depends on symptom severity, personal preferences, medical history and risks. Nonhormonal treatments are also available.
It can contribute, especially through vaginal discomfort, sleep disruption and hormonal changes, but sexual desire is multifactorial and should be evaluated broadly.
NovaGenix can review symptoms, menstrual history, medical history and treatment goals before discussing whether hormone or nonhormonal options are appropriate. Learn about Dr. Timothy Mackey, visit About NovaGenix, or review our women’s hormone therapy hub.
Call 561-277-8260 | Text NovaGenix | Schedule a Consultation
This article is educational and does not replace individualized medical advice, gynecologic evaluation or treatment.
Speak with NovaGenix about physician-led evaluation, testing, and treatment options in Jupiter, Florida.
Medical disclaimer: This article is for general educational purposes only and is not medical advice, a diagnosis, or a treatment recommendation. Reading it does not create a physician-patient relationship. Always consult a qualified healthcare professional about your individual circumstances, and never delay seeking care because of something you read here. If you are experiencing a medical emergency, call 911. Read our full Medical Disclaimer.


609 N Hepburn avenue suite 106. Jupiter, Florida 33458
609 N Hepburn avenue suite 106. Jupiter, Florida 33458
561-277-8260
Learn what you want to know about hormone therapy by scheduling a free consultation.
Contact Us Today609 N Hepburn Ave Ste 106, Jupiter, FL 33458
Monday - Friday: 9:00 am - 5:00 pm | Saturday-Sunday: Closed